Stock Repurchase
-
Shell Announces Share Buyback Program
Shell plc (SHEL) has initiated a $3.5 billion share buyback program spanning approximately three months, concluding by October 24, 2025. Executed via two $1.75 billion contracts on London and Netherlands exchanges, the program aims to reduce issued share capital by cancelling all repurchased shares, up to 602,100,000. Completion is expected before Shell’s Q3 2025 results, contingent on market conditions. The buyback demonstrates financial strength and boosts shareholder value.
-
Volcon Launches Bitcoin Treasury Program and Boosts Buyback to $100M
Volcon (VLCN) now holds 3,183.37 BTC, acquired for approximately $375 million at an average of $117,697 per Bitcoin. The company is actively managing its position by selling short-term put contracts to potentially acquire more Bitcoin at lower prices. Volcon’s board has also authorized a $100 million stock repurchase program. The company believes this treasury strategy reflects its confidence in Bitcoin as a long-term store of value. Volcon aims to offer investors efficient exposure to Bitcoin through the public equity market.
-
Torrid Holdings Inc. Announces Pricing of Secondary Stock Offering and Concurrent Share Repurchase
Torrid Holdings Inc. announced a public offering of 10,000,000 shares of common stock at $3.50, led by selling stockholders, with a closing expected around June 26, 2025. Underwriters have an option to purchase more shares. Concurrently, Torrid will repurchase $20.0 million of its stock from Sycamore Partners. Torrid will not receive proceeds from the offering. BofA Securities, Jefferies, and William Blair are managing the offering. Detailed information can be found in SEC filings.
-
ASML Announces Transactions in Ongoing Share Repurchase Program
ASML Holding executed a share buyback program from June 2-6, 2025, repurchasing 94,040 shares at prices between €643.47 and €663.09. The total value of the repurchases was approximately €61.47 million. This buyback is part of the existing capital return strategy announced on November 10, 2022, and complies with Market Abuse Regulation (Nr. 596/2014).